Lifeward Ltd. (LFWD) on Tuesday announced the appointment of Keith Rose as Chief Medical Officer.
Rose previously served as Vice President, Medical Affairs and Medical Director, Neurosciences at the company and will lead Lifeward's global medical strategy.
Rose brings more than 30 years of experience in rehabilitation medicine, neuroscience, medical affairs and patient care across the medical technology and biopharmaceutical industries.
Before joining Lifeward in 2023, Rose held senior medical affairs and clinical leadership roles at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals and Indivior.
Chief Executive Officer Mark Grant said the promotion supports the company's efforts to expand its rehabilitation technology portfolio and advance newly acquired biomedical assets.
On Monday, Lifeward closed trading 1.79% lesser at 6.58 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.